Indeed, the inhibition of VEGF/PI3K/mammalian targets of rapamycin (mTOR)/ERK signaling in HUVEC cells decreases angiogenesis, cancer growth, and metastasis [52]. The gene discussed is VEGFA; the disease is cancer.